More importantly, in vivo studies also showed that NF-κB inhibition significantly promoted the expression of the apoptosis inhibitor BCL-2 (Figure 6H) and alleviated NEC-induced severe intestinal tissue damage in mice (Figure 5A). Here, BCL2 is linked to necrotizing enterocolitis.